Figure 3.

The actuarial locoregional progress-free survival rates at 2 years for all bladder cancer patients and the patients treated with intensity-modulated radiation therapy (IMRT) and helical tomotherapy (HT).

Hsieh et al. Radiation Oncology 2011 6:75   doi:10.1186/1748-717X-6-75
Download authors' original image